Azitra (AZTR) Revenue (2022 - 2024)
Azitra (AZTR) reported Revenue of $7500.0 for Q2 2024, down 95.64% on a YoY basis from $172000.0 in Q3 2023, and down 91.67% quarter-over-quarter from $90000.0 in Q4 2023.
Azitra (AZTR) Revenue (2022 - 2024) Analysis & Trends
Azitra has reported Revenue for 3 years, with the latest figure at $7500.0 in Q2 2024.
- For the quarter ending Q2 2024, Revenue fell 95.64% year-over-year to $7500.0; the trailing twelve-month figure through Jun 2025 stood at $7500.0 (down 98.16% YoY), and the FY2024 full-year result was $7500.0, down 98.91% from the prior year.
- Revenue for Q2 2024 stood at $7500.0, down from $90000.0 in the prior quarter.
- The five-year high for Revenue was $310700.0 in Q3 2023, with the low at $7500.0 in Q2 2024.
- Historically, Revenue has averaged $107187.5 across 3 years, with a median of $87500.0 in 2022.
- Annual changes were most pronounced in 2023 — Revenue surged 540.62% — and 2024, when it slumped 95.64%.
- Azitra's Revenue stood at $30500.0 in 2022, then soared by 195.08% to $90000.0 in 2023, then sank by 91.67% to $7500.0 in 2024.
- The last three Revenue figures came in at $7500.0 (Q2 2024), $90000.0 (Q4 2023), and $310700.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 7,500.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 310,700.00 |
| Jun 30, 2023 | 172,000.00 |
| Mar 31, 2023 | 113,300.00 |
| Dec 31, 2022 | 30,500.00 |
| Sep 30, 2022 | 48,500.00 |
| Jun 30, 2022 | 85,000.00 |